Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Statera Biopharma Inc STAB

Statera BioPharma, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on developing immunotherapies autoimmune, neutropenia/anemia, emerging viruses and cancers based on a proprietary platform designed to rebalance the body’s immune system and restore homeostasis. It has platform of toll-like receptor (TLR) agonists with TLR4 and TLR9 antagonists, and the TLR5 agonists, Entolimod and GP532. The Company is developing therapies designed to directly elicit within patients a robust and durable response of antigen-specific killer T-cells and antibodies, thereby activating essential immune defenses against autoimmune, inflammatory, infectious diseases, and cancers. It has clinical programs for Crohn’s disease (STAT-201), hematology (Entolimod), pancreatic cancer (STAT-401) and COVID-19 (STAT-205) in addition to potential expansion into fibromyalgia and multiple sclerosis.


GREY:STAB - Post by User

Bullboard Posts
Post by DallasTauruson Jul 06, 2007 12:00am
646 Views
Post# 13044893

Shares Headed North Today

Shares Headed North TodayShares Were Up Strong after the Holiday; Heading North 4.59 Percent Thursday. I recently noticed some informational Q and A points on the Company website: 1. What is the stock symbol for Cleveland BioLabs, Inc. and which exchanges is the stock listed on? The stock is listed on the NASDAQ Capital Market under the symbol "CBLI" and the Boston Stock Exchange under the symbol "CFB". 2. Is Cleveland BioLabs, Inc. stock traded on any of the European exchanges? The stock is not currently listed on any foreign exchange. 3. When did Cleveland BioLabs, Inc. go public? At what price? The initial public offering was on July 21, 2006 at $6.00 per share of common stock. 4. How many shares are outstanding? There are 11,826,389 common shares outstanding. 5. Can I purchase share directly from the company? You must purchase shares through your own brokerage firm. 6. Do you anticipate paying a dividend? The Board of Directions can decide to pay dividends at its discretion based on the financial condition, results of operation, capital requirements, contractual obligations, and other relevant factors. We do not expect to pay dividends in the first several years following the offering. 7. Does Cleveland BioLabs, Inc. plan on offering a direct investment program? There is currently no direct investment program. 8. Who were the underwriters for the Cleveland BioLabs, Inc. IPO? The initial public offering was underwritten by the following participating firms: Sunrise Securities Corp. Roth Capital Partners 9. Who is the transfer agent? The transfer agent is: Continental Stock Transfer & Trust Company. 17 Battery Place 8th Floor New York, NY 10004 Tel: (212)509-4000 Fax: (212)509-5150 10. Who should I notify to change my mailing address? An email to our website will handle this. 11. When is the annual stockholder meeting held? The meeting date has not yet been set, but it will be posted on the website once that happens. 12. What is the fiscal year-end for Cleveland BioLabs, Inc.? The fiscal year ends on December 31st. 13. How many employees does Cleveland BioLabs, Inc. have? There are currently 24 full-time employees. 14. Can I get an investor's packet or a copy of Cleveland BioLabs, Inc. prospectus? Please refer to the Investor Relation contact form.
Bullboard Posts